Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 229,000 | 215,000 | 208,000 | 202,000 | 233,000 |
| Accounts receivable | 1,000 | 92,000 | -33,000 | -779,000 | 93,000 |
| Accounts payable and accrued liabilities | -210,000 | 71,000 | -2,000 | 120,000 | 0 |
| Other Working Capital | -203,000 | 86,000 | -74,000 | -300,000 | 150,000 |
| Other Operating Activity | -422,000 | 960,000 | 1,037,000 | 1,975,000 | 539,000 |
| Operating Cash Flow | $-605,000 | $1,424,000 | $1,136,000 | $1,218,000 | $1,015,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -371,000 | -182,000 | -167,000 | -132,000 | -423,000 |
| Net Acquisitions | -15,000 | -233,000 | -31,000 | -156,000 | -38,000 |
| Sale Of Investment | N/A | N/A | 0 | 0 | 10,000 |
| Other Investing Activity | 147,000 | -364,000 | -10,000 | -4,000 | 7,000 |
| Investing Cash Flow | $-239,000 | $-779,000 | $-208,000 | $-292,000 | $-444,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -242,000 | 0 | N/A | N/A | 0 |
| Common Stock Issued | 8,000 | 9,000 | 7,000 | 16,000 | 8,000 |
| Common Stock Repurchased | -489,000 | -393,000 | -470,000 | -499,000 | -593,000 |
| Dividend Paid | -240,000 | -219,000 | -222,000 | -227,000 | -227,000 |
| Other Financing Activity | 1,469,000 | 3,000 | 13,000 | 0 | 2,000 |
| Financing Cash Flow | $506,000 | $-600,000 | $-672,000 | $-710,000 | $-810,000 |
| Exchange Rate Effect | 20,000 | -8,000 | 32,000 | 0 | N/A |
| Beginning Cash Position | 2,709,000 | 2,672,000 | 2,384,000 | 2,168,000 | 2,463,000 |
| End Cash Position | 2,391,000 | 2,709,000 | 2,672,000 | 2,384,000 | 2,168,000 |
| Net Cash Flow | $-338,000 | $45,000 | $256,000 | $216,000 | $-239,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -605,000 | 1,424,000 | 1,136,000 | 1,218,000 | 1,015,000 |
| Capital Expenditure | -371,000 | -182,000 | -167,000 | -132,000 | -423,000 |
| Free Cash Flow | -976,000 | 1,242,000 | 969,000 | 1,086,000 | 592,000 |